抄録
Drug delivery technologies for reformulation of parenteral therapeutics has received a lot of attention in recent years, due to significant advances in the field. There is a growing need for patient compliant dosage forms within the cancer therapeutics and biotechnology areas. Besides patient compliance, ease of administration, enhanced therapeutic efficacy, and reduced side effects, are additional factors that differentiate drug delivery products from conventional dosage forms, thus providing a competitive advantage.
This article reviews some salient trends in the parenteral drug delivery sector, within the realms of a changing regulatory environment. Drivers to growth as well as recent advances in this field have been reviewed. Finally, challenges associated with bringing parenteral drug delivery concepts to commercialization have also been discussed.
